fig4
Figure 4. Results from PRODIGE 12-ACCORD 18 trial. (A) Relapse-free and (B) overall survival comparing adjuvant gemcitabine-oxaliplatin versus observation.
Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)
Navigation
Follow Us
Navigation
Portico
All published articles are preserved here permanently:
https://www.portico.org/publishers/oae/
